(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Systemic Lupus Erythematosus
If you are a SL0007 patient who completed week eight of the study or later, you may qualify to participate in this new study.
The research site is in Oklahoma City, Okla.
If you are 50 or older, postmenopausal, and have a lack of sexual desire, you may qualify for this study of an investigational drug.
The research site is in Charlottesville, Va.
If you are at least 18, have been diagnosed with HER2-positive metastatic breast cancer, and are eligible for chemotherapy, you may qualify for this study.
The research site is in Pittsburgh, Penn.
Copyright 2008 Thomson CenterWatch. All rights reserved.